Volume 132, Issue 5, Pages (May 2007)

Slides:



Advertisements
Similar presentations
Volume 142, Issue 4, Pages (April 2012)
Advertisements

Volume 139, Issue 1, Pages e7 (July 2010)
Volume 135, Issue 5, Pages (November 2008)
Covering the Cover Gastroenterology
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 5, Pages (November 2002)
Volume 133, Issue 2, Pages (August 2007)
Volume 133, Issue 5, Pages (November 2007)
Volume 138, Issue 1, Pages (January 2010)
Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension  Don C. Rockey, John J. Chung 
Volume 143, Issue 5, Pages e1 (November 2012)
Volume 139, Issue 1, Pages e7 (July 2010)
Volume 137, Issue 2, Pages e2 (August 2009)
Volume 142, Issue 4, Pages (April 2012)
Covering the Cover Gastroenterology
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
Volume 133, Issue 2, Pages (August 2007)
Volume 132, Issue 4, Pages (April 2007)
Volume 136, Issue 2, Pages (February 2009)
Establishment of Endoderm Progenitors by SOX Transcription Factor Expression in Human Embryonic Stem Cells  Cheryle A. Séguin, Jonathan S. Draper, Andras.
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 150, Issue 3, Pages (March 2016)
Volume 136, Issue 3, Pages (March 2009)
Volume 127, Issue 5, Pages (November 2004)
Volume 16, Issue 12, Pages (September 2016)
Volume 146, Issue 5, Pages e1 (May 2014)
Volume 137, Issue 6, Pages e2 (December 2009)
Volume 139, Issue 3, Pages (September 2010)
Volume 45, Issue 1, Pages (July 2016)
Reduced Expression of Ferroportin-1 Mediates Hyporesponsiveness of Suckling Rats to Stimuli That Reduce Iron Absorption  Deepak Darshan, Sarah J. Wilkins,
Volume 133, Issue 6, Pages (December 2007)
Volume 123, Issue 4, Pages (October 2002)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 140, Issue 5, Pages (May 2011)
Volume 138, Issue 7, Pages (June 2010)
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Volume 143, Issue 3, Pages e3 (September 2012)
Volume 142, Issue 4, Pages (April 2012)
Volume 146, Issue 7, Pages (June 2014)
Volume 134, Issue 3, Pages (March 2008)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 136, Issue 7, Pages (June 2009)
Volume 141, Issue 5, Pages (November 2011)
Volume 140, Issue 3, Pages e8 (March 2011)
Volume 127, Issue 1, Pages (July 2004)
Volume 140, Issue 2, Pages e4 (February 2011)
Volume 143, Issue 1, Pages e7 (July 2012)
Volume 135, Issue 5, Pages (November 2008)
Volume 138, Issue 2, Pages (February 2010)
Volume 142, Issue 2, Pages (February 2012)
Volume 16, Issue 12, Pages (September 2016)
Volume 135, Issue 2, Pages (August 2008)
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 137, Issue 4, Pages (October 2009)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 130, Issue 7, Pages (June 2006)
Volume 127, Issue 3, Pages (September 2004)
Sulfatide-Mediated Activation of Type II Natural Killer T Cells Prevents Hepatic Ischemic Reperfusion Injury In Mice  Philomena Arrenberg, Igor Maricic,
Volume 9, Issue 4, Pages (November 2014)
Volume 141, Issue 3, Pages (September 2011)
Volume 19, Issue 5, Pages (November 2003)
Volume 127, Issue 4, Pages (October 2004)
Volume 132, Issue 5, Pages (May 2007)
Volume 41, Issue 4, Pages (October 2014)
Molecular Therapy - Nucleic Acids
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Volume 137, Issue 6, Pages e2 (December 2009)
Michael U. Shiloh, Paolo Manzanillo, Jeffery S. Cox 
Glial cell line-derived neurotrophic factor (GDNF) induces hepatic stellate cell (HSC) activation in human HSCs. Gdnf mRNA expression as determined by.
Presentation transcript:

Volume 132, Issue 5, Pages 1937-1946 (May 2007) Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo  Samuele De Minicis, Ekihiro Seki, Hiroshi Uchinami, Johannes Kluwe, Yonghui Zhang, David A. Brenner, Robert F. Schwabe  Gastroenterology  Volume 132, Issue 5, Pages 1937-1946 (May 2007) DOI: 10.1053/j.gastro.2007.02.033 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Combination of collagenase-pronase based density centrifugation and MACS achieves high purity of quiescent and activated hepatic stellate cells. (A and B) Hepatic stellate cells were isolated from normal mice and mice that underwent BDL for 2 weeks and were either depleted of CD11b- and F4/80-expressing cells or left untreated. Expression of CD11b and F4/80 was analyzed by flow cytometric analysis (A). Expression of CD68 in quiescent HSCs (“Q”), culture-activated HSCs (“A”), BDL-activated HSCs (“B”), and CCl4-activated HSCs (“C”) was measured by quantitative real-time PCR (B). Results were normalized to 18S and are expressed as fold induction ± standard error of the mean in comparison to Kupffer cells (“KC” = 100%). (C and D) Contamination of Kupffer cell-depleted HSCs with hepatocytes (C) and endothelial cells (D) was measured by quantitative real-time PCR for albumin and CD31, respectively. Results were normalized to 18S and are expressed as fold induction ± standard error of the mean in comparison with primary hepatocytes (“Hep” = 100%) and primary hepatic endothelial cells (“EC” = 100%). (E) To demonstrate purity and activation status, HSCs were isolated from transgenic mice expressing GFP under the collagen α1(I) promoter. GFP and retinoid autofluorescence were checked 1 day after isolation in quiescent HSC and HSC isolated from bile duct-ligated (“BDL”) and CCl4-treated mice and after 5 days in culture-activated HSCs. Gastroenterology 2007 132, 1937-1946DOI: (10.1053/j.gastro.2007.02.033) Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Combination of collagenase-pronase based density centrifugation and MACS achieves high purity of quiescent and activated hepatic stellate cells. (A and B) Hepatic stellate cells were isolated from normal mice and mice that underwent BDL for 2 weeks and were either depleted of CD11b- and F4/80-expressing cells or left untreated. Expression of CD11b and F4/80 was analyzed by flow cytometric analysis (A). Expression of CD68 in quiescent HSCs (“Q”), culture-activated HSCs (“A”), BDL-activated HSCs (“B”), and CCl4-activated HSCs (“C”) was measured by quantitative real-time PCR (B). Results were normalized to 18S and are expressed as fold induction ± standard error of the mean in comparison to Kupffer cells (“KC” = 100%). (C and D) Contamination of Kupffer cell-depleted HSCs with hepatocytes (C) and endothelial cells (D) was measured by quantitative real-time PCR for albumin and CD31, respectively. Results were normalized to 18S and are expressed as fold induction ± standard error of the mean in comparison with primary hepatocytes (“Hep” = 100%) and primary hepatic endothelial cells (“EC” = 100%). (E) To demonstrate purity and activation status, HSCs were isolated from transgenic mice expressing GFP under the collagen α1(I) promoter. GFP and retinoid autofluorescence were checked 1 day after isolation in quiescent HSC and HSC isolated from bile duct-ligated (“BDL”) and CCl4-treated mice and after 5 days in culture-activated HSCs. Gastroenterology 2007 132, 1937-1946DOI: (10.1053/j.gastro.2007.02.033) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 The gene expression pattern of culture-activated HSCs is different from that of BDL- and CCl4-activated HSCs. Hepatic stellate cells were isolated from normal mice and mice that underwent BDL for 2 weeks or 4 CCl4 injections. HSCs were considered culture activated after 5 days of culture in 10% fetal bovine serum on uncoated cell culture dishes. After isolation of mRNA and generation of cRNA, microarray was performed. (A) Shown is a representative graph of 3 separate HSC isolations per group (“1,” “2,” and “3”) containing all genes that were more than 2-fold up-regulated (shown in red) or down-regulated (shown in blue) in at least 1 of the 3 groups of activated HSCs in comparison with quiescent HSCs (t test, P < .05 followed by Benjamini–Hochberg correction). (B) The relative expression of all 45,000 probe sets of the array was correlated among culture-activated HSCs, BDL-activated HSCs, and CCl4-activated HSCs using Spearman rank correlation. (C) The Venn diagram shows overlapping patterns of probe sets that were significantly (P < .05) and at least 2-fold up-regulated and down-regulated in 1 of the 3 groups of activated HSCs. Probe sets that were 2-fold up-regulated or down-regulated in one group were considered down-regulated or up-regulated in the other groups if they showed at least 1.5-fold up-regulation or down-regulation. Gastroenterology 2007 132, 1937-1946DOI: (10.1053/j.gastro.2007.02.033) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Identification of previously known and novel differentially regulated genes during HSC activation in vivo and in culture. (A) Expression of differentially regulated genes was confirmed in quiescent HSCs (“Q”), culture-activated HSCs (“A”), BDL-activated HSCs (“B”), and CCl4-activated HSCs (“C”) by qPCR. Results were normalized to 18S and are expressed as fold induction ± standard error of the mean in comparison with quiescent HSCs. Each group of HSC samples consisted of at least 3 different isolations. (B) Expression of selected genes was confirmed by Western blot analysis. Each Western blot is based on HSCs isolated from 3 normal, BDL-, or CCl4-treated mice and is representative of at least 2 independent experiments. Gastroenterology 2007 132, 1937-1946DOI: (10.1053/j.gastro.2007.02.033) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Exposure of HSCs to Kupffer cells or LPS during culture shifts the gene expression toward the pattern of in vivo-activated HSCs. (A and B) Genes that showed a different expression pattern during culture and in vivo activation were examined after 5 days of culture activation in the presence or absence of Kupffer cells or LPS (100 ng/mL) by quantitative real-time PCR as described in the Materials and Methods section (“Q,” quiescent; “A,” culture activated without additional stimuli; “K,” Kupffer cell treated; “L,” LPS treated). Shown is the mean of PCRs from 3 independent HSC isolations. (C) The influence of Kupffer cells and LPS on the expression of selected genes was confirmed by Western blot analysis. For this purpose, HSCs were cultured in the presence or absence of Kupffer cells in a noncontact-dependent manner for 5 days or in the presence of LPS (100 ng/mL). This experiment is representative of at least 2 independent HSC isolations. Gastroenterology 2007 132, 1937-1946DOI: (10.1053/j.gastro.2007.02.033) Copyright © 2007 AGA Institute Terms and Conditions